Cleared Traditional

K842593 - SUCROSEP THYROID STIMULATING HORMONE

K842593 is an FDA 510(k) clearance for SUCROSEP THYROID STIMULATING HORMONE, manufactured by Boots-Celltech Diagnostics, Inc.. The device is a Class 2 Chemistry device with product code JLW cleared through the Traditional 510(k) pathway after a 71-day FDA review.

K842593 · Boots-Celltech Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1984
Decision
71d
Days
Class 2
Risk

K842593 is an FDA 510(k) clearance for the SUCROSEP THYROID STIMULATING HORMONE. Classified as Radioimmunoassay, Thyroid-stimulating Hormone (product code JLW), Class II - Special Controls.

Submitted by Boots-Celltech Diagnostics, Inc. (Walker, US). The FDA issued a Cleared decision on September 12, 1984 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1690 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Boots-Celltech Diagnostics, Inc. devices

FDA 510(k) Submission Details - K842593

510(k) Number K842593 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 03, 1984
Decision Date September 12, 1984
Days to Decision 71 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
17d faster than avg
Panel avg: 88d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JLW Device Classification - Class 2, Special Controls

Product Code JLW Radioimmunoassay, Thyroid-stimulating Hormone
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1690
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JLW Radioimmunoassay, Thyroid-stimulating Hormone

All 201
Devices cleared under the same product code (JLW) and FDA review panel - the closest regulatory comparables to K842593.
ENCORE TSH REAGENT
K843395 · Hybritech, Inc. · Oct 1984
TSH QUIK RIA KIT
K843545 · Pacific Biotech, Inc. · Oct 1984
ACCUSCREEN TSH
K843281 · Neometrics, Inc. · Sep 1984
AMERLEX-M TSH RIA
K842948 · Amersham Corp. · Sep 1984
BLOOD SPOT NEONATAL TSH RADIOIMMUNO
K841606 · Bd Becton Dickinson Vacutainer Systems Preanalytic · May 1984
BIODEX ACT-O-KIT TSH-RIA-
K840088 · Biodan Medical Systems, Ltd. · May 1984